Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis
American Journal of Respiratory Cell and Molecular Biology · 01.02.2023 · 68 (2) · 213-227
DOI: 10.1165/rcmb.2022-0056oc ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, online erschienen am 01.02.2023. Verfasst von Zhe Zhang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The First Hospital of Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Pneumonia, Lung Diseases, Interstitial. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Key Research and Development Program of China Grant, Non-Profit Central Research Institute Fund of the Chinese Academy of Medical Sciences, National Key Research and Development Program of China Grants.
Abstract (Originalsprache)
Progressive fibrosing interstitial lung diseases (PF-ILDs) result in high mortality and lack effective therapies. The pathogenesis of PF-ILDs involves macrophages driving inflammation and irreversible fibrosis. Fc-γ receptors (FcγRs) regulate macrophages and inflammation, but their roles in PF-ILDs remain unclear. We characterized the expression of FcγRs and found upregulated FcγRIIB in human and mouse lungs after exposure to silica. FcγRIIB deficiency aggravated lung dysfunction, inflammation, and fibrosis in silica-exposed mice. Using single-cell transcriptomics and in vitro experiments, FcγRIIB was found in alveolar macrophages, where it regulated the expression of fibrosis-related genes Spp1 and Ctss. In mice with macrophage-specific overexpression of FcγRIIB and in mice treated with adenovirus by intratracheal instillation to upregulate FcγRIIB, silica-induced functional and histological changes were ameliorated. Our data from three genetic models and a therapeutic model suggest that FcγRIIB plays a protective role that can be enhanced by adenoviral overexpression, representing a potential therapeutic strategy for PF-ILDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The First Hospital of Shanxi Medical University, Taiyuan, China.
- Department of Physiology and.
- Department of Pathophysiology, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
- National Health Commission Key Laboratory of Pneumoconiosis, Taiyuan, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiao tong University, Xi'an, China; and.
- Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
ORCID-Profile: Peiran Yang
Förderung
- National Key Research and Development Program of China Grant
- Non-Profit Central Research Institute Fund of the Chinese Academy of Medical Sciences
- National Key Research and Development Program of China Grants
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
Zitieren
APA
Zhang, Z., Cao, Z., Hou, L., Song, M., Zhou, Y., Chen, Y., Hu, H., Hou, Y., Liu, Y., Li, B., Song, X., Ge, W., Li, B., Jiang, X., Yang, J., Song, D., Zhang, X., Pang, J., Zhang, T., …, & Wang, C. (2023). Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis. American Journal of Respiratory Cell and Molecular Biology, 68(2), 213-227. https://doi.org/10.1165/rcmb.2022-0056oc
Vancouver
Zhang Z, Cao Z, Hou L, Song M, Zhou Y, Chen Y, et al. Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 2023;68(2):213-227. doi:10.1165/rcmb.2022-0056oc
BibTeX
@article{Zhang2023,
author = {Zhang, Zhe and Cao, Zhujie and Hou, Lin and Song, Meiyue and Zhou, Yitian and Chen, Yiling and Hu, Huiyuan and Hou, Yangfeng and Liu, Ying and Li, Bolun and Song, Xiaomin and Ge, Weipeng and Li, Baicun and Jiang, Xuehan and Yang, Jie and Song, Dingyun and Zhang, Xinri and Pang, Junling and Zhang, Tiantian and Zhang, Hong and Yang, Peiran and Wang, Jing and Wang, Chen},
title = {Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis},
journal = {American Journal of Respiratory Cell and Molecular Biology},
year = {2023},
volume = {68},
number = {2},
pages = {213--227},
doi = {10.1165/rcmb.2022-0056oc}
}
EUVIMED